a nonsignificant trendP = 0.06
A nonsignificant trend for regression was also observed for metformin (1.25, P = 0.06), male sex (1.17, P = 0.08), and insulin sensitivity (1.07, P = 0.09).
A nonsignificant trend for regression was also observed for metformin (1.25, P = 0.06), male sex (1.17, P = 0.08), and insulin sensitivity (1.07, P = 0.09).
No significant differences were observed between the randomized groups by treatment assignment for the variables shown, except for diastolic blood pressure and HDL cholesterol that were borderline significant.
The relationship between ILS and regression to IFG was of borderline significance.